Calcium, an essential mineral, plays a pivotal role in sustaining the health and function of the human skeletal system. Its significance in bone metabolism is a subject of great interest in medical science. This article aims to provide a comprehensive review of calcium's integral role in bone metabolism, elucidating its mechanisms and clinical implications.
Calcium is the most abundant mineral in the human body, with 99% stored in the bones and teeth. It contributes to bone strength and structure, and is involved in critical metabolic functions such as nerve transmission, muscle contraction, and blood clotting. The interplay between dietary calcium intake, absorption, excretion, and bone remodeling underscores its role in maintaining bone health.
Bone remodeling, a continuous process of bone formation and resorption, is significantly influenced by calcium levels. Osteoblasts (cells responsible for bone formation) and osteoclasts (cells responsible for bone resorption) work in tandem to maintain bone homeostasis. Any imbalance in this process, often linked to calcium deficiencies, can lead to bone diseases such as osteoporosis.
Calcium homeostasis is a tightly regulated process involving the parathyroid hormone (PTH) and vitamin D. PTH increases blood calcium levels by stimulating osteoclast activity and enhancing renal reabsorption of calcium. Vitamin D promotes intestinal absorption of calcium. Disruptions in this regulatory system can result in hypercalcemia or hypocalcemia, with potential adverse effects on cardiovascular, renal, and neurological health.
Understanding the integral role of calcium in bone metabolism is crucial for healthcare professionals. It informs the approach to prevention, diagnosis, and treatment of bone-related diseases. Further research into the complex interactions between calcium, bone health, and overall metabolism will undoubtedly enhance our ability to manage and prevent skeletal disorders effectively.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation